HERZUMA

Google image searchProduct monograph

Active ingredient

trastuzumab, 440 MG/VIAL

DIN: 02480794

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: CONTAINS 1 VIAL OF POWDER AND 1 VIAL OF DILUENT

Schedule: Prescription / Schedule D

Company: CELLTRION INC.

Date: 03-OCT-2024

ATC:

Reference brand drug: Herceptin

Search on Google